Schering Korea to launch injectable testosterone for male climacterics.

Schering Korea has launched Nebido, an injectable testosterone hormone for the male climacteric syndrome, administering once every 3 month to keep a normal blood level of testosterone to eliminate any possible roller coaster effect that might be raised with other common hormone therapy.

Most of long acting testosterone preparations used to administer every 2 to 3 week, giving many inconvenie...